Form 4: Modular Medical Director Acquires Stock Options
Insider Transaction Report
Modular Medical Director Morgan C. Frank acquired options to purchase common stock, fully vested and exercisable on the grant date, as part of the company's director compensation plan.
Summary
- Morgan C. Frank, a Director and 10% Owner of Modular Medical, Inc. (MODD), acquired options to purchase common stock.
- The transactions took place on December 31, 2025.
- Two separate grants were made: 1,875 options and 7,500 options, totaling 9,375 options.
- Each option has an exercise price of $0.36.
- All options were fully vested and exercisable on the grant date, December 31, 2025, and are set to expire on December 31, 2035.
- These options were granted to the Reporting Person in accordance with the Issuer's Outside Director Compensation Plan.
Sentiment
Score: 6
Explanation: The acquisition of stock options by a director and 10% owner, especially fully vested ones, is generally viewed as a neutral to slightly positive signal, indicating continued alignment of interests and potential confidence in the company's future.
Positives
- A Director and 10% Owner, Morgan C. Frank, acquired options, which can signal confidence in the company's future prospects.
- The options were fully vested and exercisable on the grant date, providing immediate equity exposure to the director.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future financial performance or strategic direction.
Industry Context
Insider transactions, such as the acquisition of stock options by a director, are common practices in publicly traded companies. They are often part of executive and director compensation packages designed to align the interests of management with those of shareholders. The immediate vesting of these options is typical for director grants, reflecting compensation for past or ongoing service.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Adherence | The options were granted in accordance with the Issuer's Outside Director Compensation Plan, indicating a structured and pre-approved method for director remuneration. | 12/31/2025 | This demonstrates adherence to established corporate governance policies regarding director compensation, promoting transparency and alignment of interests. |
Stakeholder Impact
- Shareholders may view the director's acquisition of options as a positive sign of management's commitment and belief in the company's long-term value, potentially fostering investor confidence.
Next Steps
- The reporting person may choose to exercise the options at any time before the expiration date of December 31, 2035, to acquire common stock.
Key Dates
| Date | Description |
|---|---|
| 12/31/2025 | Date of earliest transaction and grant date for stock options. |
| 12/31/2025 | Date options became fully exercisable. |
| 01/02/2026 | Signature date of the reporting person on the Form 4 filing. |
| 12/31/2035 | Expiration date for the acquired stock options. |
Keywords
Modular Medical, MODD, Stock Options, Insider Transaction, Director Compensation, Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.